437 related articles for article (PubMed ID: 31903983)
21. Development and validation of an immune and stromal prognostic signature in uveal melanoma to guide clinical therapy.
Gong Q; Wan Q; Li A; Yu Y; Ding X; Lin L; Qi X; Hu L
Aging (Albany NY); 2020 Oct; 12(20):20254-20267. PubMed ID: 33100273
[TBL] [Abstract][Full Text] [Related]
22. Spliceosome Mutations in Uveal Melanoma.
Nguyen JQN; Drabarek W; Yavuzyigitoglu S; Medico Salsench E; Verdijk RM; Naus NC; de Klein A; Kiliç E; Brosens E
Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33333932
[TBL] [Abstract][Full Text] [Related]
23.
Meng Z; Chen Y; Wu W; Yan B; Zhang L; Chen H; Meng Y; Liang Y; Yao X; Luo J
Front Immunol; 2022; 13():754645. PubMed ID: 35281030
[TBL] [Abstract][Full Text] [Related]
24. A novel lncRNA-miRNA-mRNA competitive endogenous RNA network for uveal melanoma prognosis constructed by weighted gene co-expression network analysis.
Yu H; Cheng Y; Li W; Li Z; Wu P; Qiu S; Zeng B; Huang B
Life Sci; 2020 Nov; 260():118409. PubMed ID: 32926921
[TBL] [Abstract][Full Text] [Related]
25. Knockdown of thrombospondin 2 inhibits metastasis through modulation of PI3K signaling pathway in uveal melanoma cell line M23.
Liu QH; Ma LS
Eur Rev Med Pharmacol Sci; 2018 Oct; 22(19):6230-6238. PubMed ID: 30338785
[TBL] [Abstract][Full Text] [Related]
26. Construction and verification of a hypoxia-related nine-gene prognostic model in uveal melanoma based on integrated single-cell and bulk RNA sequencing analyses.
Zhang X; Qiu J; Huang F; Han P; Shan K; Zhang C
Exp Eye Res; 2022 Oct; 223():109214. PubMed ID: 35981602
[TBL] [Abstract][Full Text] [Related]
27. Identification of Prognostic alternative splicing signatures and their clinical significance in uveal melanoma.
Zhou W; Fei P; Li J
Exp Eye Res; 2021 Aug; 209():108666. PubMed ID: 34129849
[TBL] [Abstract][Full Text] [Related]
28. Prognostic Implications of Tumor Diameter in Association With Gene Expression Profile for Uveal Melanoma.
Walter SD; Chao DL; Feuer W; Schiffman J; Char DH; Harbour JW
JAMA Ophthalmol; 2016 Jul; 134(7):734-40. PubMed ID: 27123792
[TBL] [Abstract][Full Text] [Related]
29. MicroRNA expression analysis and Multiplex ligation-dependent probe amplification in metastatic and non-metastatic uveal melanoma.
Larsen AC; Holst L; Kaczkowski B; Andersen MT; Manfé V; Siersma VD; Kolko M; Kiilgaard JF; Winther O; Prause JU; Gniadecki R; Heegaard S
Acta Ophthalmol; 2014 Sep; 92(6):541-9. PubMed ID: 24373459
[TBL] [Abstract][Full Text] [Related]
30. The prognostic landscape of adaptive immune resistance signatures and infiltrating immune cells in the tumor microenvironment of uveal melanoma.
Wang Y; Xu Y; Dai X; Lin X; Shan Y; Ye J
Exp Eye Res; 2020 Jul; 196():108069. PubMed ID: 32439398
[TBL] [Abstract][Full Text] [Related]
31. Reduced expression of autotaxin predicts survival in uveal melanoma.
Singh AD; Sisley K; Xu Y; Li J; Faber P; Plummer SJ; Mudhar HS; Rennie IG; Kessler PM; Casey G; Williams BG
Br J Ophthalmol; 2007 Oct; 91(10):1385-92. PubMed ID: 17475713
[TBL] [Abstract][Full Text] [Related]
32. Identification of Six Autophagy-Related-lncRNA Prognostic Biomarkers in Uveal Melanoma.
Chen Y; Chen L; Wang J; Tan J; Wang S
Dis Markers; 2021; 2021():2401617. PubMed ID: 34426753
[TBL] [Abstract][Full Text] [Related]
33. Repression of genes involved in melanocyte differentiation in uveal melanoma.
Bergeron MA; Champagne S; Gaudreault M; Deschambeault A; Landreville S
Mol Vis; 2012; 18():1813-22. PubMed ID: 22815634
[TBL] [Abstract][Full Text] [Related]
34. Identification of a prognostic six-immune-gene signature and a nomogram model for uveal melanoma.
Yang B; Fan Y; Liang R; Wu Y; Gu A
BMC Ophthalmol; 2023 Jan; 23(1):2. PubMed ID: 36597071
[TBL] [Abstract][Full Text] [Related]
35. A Novel Ferroptosis-Associated Gene Signature to Predict Prognosis in Patients with Uveal Melanoma.
Luo H; Ma C
Diagnostics (Basel); 2021 Feb; 11(2):. PubMed ID: 33540700
[TBL] [Abstract][Full Text] [Related]
36. Identification of a novel immune-related gene signature for prognosis and the tumor microenvironment in patients with uveal melanoma combining single-cell and bulk sequencing data.
Wang W; Zhao H; Wang S
Front Immunol; 2023; 14():1099071. PubMed ID: 36793711
[TBL] [Abstract][Full Text] [Related]
37. Identification of prognostic alternative splicing signatures in uveal melanoma.
Xie X; Zheng X; Xie T; Cai J; Yao Y
Int Ophthalmol; 2021 Apr; 41(4):1347-1362. PubMed ID: 33479809
[TBL] [Abstract][Full Text] [Related]
38. Immune implication of an autophagy-related prognostic signature in uveal melanoma.
Chuah S; Chew V
Biosci Rep; 2021 Aug; 41(8):. PubMed ID: 34374416
[TBL] [Abstract][Full Text] [Related]
39. The Prognostic Value of AJCC Staging in Uveal Melanoma Is Enhanced by Adding Chromosome 3 and 8q Status.
Dogrusöz M; Bagger M; van Duinen SG; Kroes WG; Ruivenkamp CA; Böhringer S; Andersen KK; Luyten GP; Kiilgaard JF; Jager MJ
Invest Ophthalmol Vis Sci; 2017 Feb; 58(2):833-842. PubMed ID: 28159971
[TBL] [Abstract][Full Text] [Related]
40. Development and Validation of a Novel Metabolic Signature-Based Prognostic Model for Uveal Melanoma.
Shi K; Li X; Zhang J; Sun X
Transl Vis Sci Technol; 2022 May; 11(5):9. PubMed ID: 35536719
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
